The Neurona Therapeutics team (Credit: Neurona)
April 3, 2025 06:00 AM EDT
Financing
Startups
Cell/Gene Tx

Ex­clu­sive: Neu­rona bags $102M to treat epilep­sy with cell ther­a­py

Kyle LaHucik

Senior Reporter

A few cell and gene ther­a­py biotechs are do­ing al­right this week.

The lat­est is Neu­rona Ther­a­peu­tics, which ex­clu­sive­ly told End­points News that it col­lect­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Marks was asked to pro­vide non-ex­is­tent vac­cine risk da­ta: WSJ

Kennedy team de­fends Marks fir­ing, while 20% of staff cuts may be 'mis­takes'

Se­cre­tive Chi­nese start­up be­gins first-ever clin­i­cal tri­al of cir­cu­lar RNA ther­a­py

No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times